Mannkind Corp (MNKD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
5.04 +0.13 (+2.65%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 5.12 +0.08 (+1.59%) 19:39 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select FieldsSymbol | MNKD | MESO | GPCR | ||
Company | Mannkind Corp | Mesoblast Ltd ADR | Structure Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 4.91 | 11.50 | 25.50 | ||
High | 5.09 | 11.51 | 28.16 | ||
Low | 4.88 | 11.03 | 25.29 | ||
Last | 5.04 | 11.40 | 27.00 | ||
Change | +0.13 | -0.51 | +1.09 | ||
% Change | +2.65% | -4.28% | +4.21% | ||
Volume | 2,008,900 | 92,900 | 1,498,800 | ||
20-Day Average Volume | 1,994,200 | 200,430 | 1,289,895 | ||
Previous Close | 4.91 | 11.91 | 25.91 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 4.70 | 10.96 | 19.73 | ||
20-Day Raw Stochastic | 92.72% | 70.75% | 92.24% | ||
20-Day Relative Strength | 53.52% | 44.75% | 66.06% | ||
Weighted Alpha | +1.18 | +15.57 | -48.68 | ||
Today's Opinion | 64% Sell | 32% Sell | 40% Sell | ||
Previous Opinion | 88% Sell | 24% Sell | 40% Sell | ||
Last Month's Opinion | 88% Sell | 8% Buy | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +9.33% since 04/23/25 | +2.70% since 04/23/25 | +15.78% since 04/23/25 | ||
Low | 4.58 on 04/24/25 | 11.03 on 04/30/25 | 22.79 on 04/24/25 | ||
High | 5.09 on 04/30/25 | 12.03 on 04/29/25 | 28.16 on 04/30/25 | ||
1-Month | |||||
%Chg | +0.20% since 03/28/25 | -5.86% since 03/28/25 | +36.57% since 03/28/25 | ||
Low | 4.34 on 04/09/25 | 9.61 on 04/07/25 | 13.22 on 04/09/25 | ||
High | 5.09 on 04/30/25 | 12.58 on 03/31/25 | 28.16 on 04/30/25 | ||
3-Month | |||||
%Chg | -15.58% since 01/30/25 | -41.60% since 01/30/25 | -10.95% since 01/30/25 | ||
Low | 4.34 on 04/09/25 | 9.61 on 04/07/25 | 13.22 on 04/09/25 | ||
High | 5.98 on 01/31/25 | 21.00 on 01/31/25 | 31.72 on 01/31/25 | ||
6-Month | |||||
%Chg | -28.21% since 10/30/24 | +29.40% since 10/30/24 | -28.68% since 10/30/24 | ||
Low | 4.34 on 04/09/25 | 7.09 on 11/01/24 | 13.22 on 04/09/25 | ||
High | 7.63 on 11/06/24 | 22.00 on 12/30/24 | 42.57 on 10/31/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,491,879 | 1,521,836 | 1,485,757 | ||
Shares Outstanding, K | 303,845 | 127,778 | 57,343 | ||
Annual Sales | 285,500,000 | 5,900,000 | 0 | ||
Annual Net Income | 27,590,000 | -87,960,000 | -122,530,000 | ||
Last Quarter Sales | 76,780,000 | 1,930,000 | 0 | ||
Last Quarter Net Income | 7,420,000 | -21,920,000 | -36,480,000 | ||
60-Month Beta | 1.22 | 3.48 | -1.35 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.03 on 02/26/25 | N/A on 09/06/19 | -0.22 on 02/27/25 | ||
Latest Earnings Date | 05/14/25 | 09/04/24 | 05/08/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 29.56 | 0.00 | 0.00 |